title: [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
abstract: The authors relate their one-year experience in percutaneous embolization of 12 patients presenting with severe epistaxis because of a Rendu Osler disease. Using Ethibloc a sclerosing substance derived from maize in direct intramucosal injection seems to be a promising technique. Ethibloc is still used successfully in percutaneous treatment of superficial venous angiomas.
authors.affiliation: Service ORL, Hôpital Lariboisière, Paris.
authors.forename: M
authors.initials: M
authors.lastname: Borsik
authors.forename: D
authors.initials: D
authors.lastname: Herbreteau
authors.forename: D
authors.initials: D
authors.lastname: Deffrennes
authors.forename: J P
authors.initials: JP
authors.lastname: Guichard
authors.forename: A
authors.initials: A
authors.lastname: Aymard
authors.forename: J J
authors.initials: JJ
authors.lastname: Merland
authors.forename: P
authors.initials: P
authors.lastname: Tran Ba Huy
mesh_terms: D000328:Adult; D000368:Aged; D003973:Diatrizoate; D004338:Drug Combinations; D004621:Embolization, Therapeutic / Q000379:methods*; D004844:Epistaxis / Q000209:etiology / Q000628:therapy*; D005227:Fatty Acids; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011409:Propylene Glycols; D011506:Proteins / Q000627:therapeutic use*; D012189:Retrospective Studies; D012597:Sclerosing Solutions; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications / Q000628:therapy*; D015028:Zein
chemical_list: D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D012597:Sclerosing Solutions; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution
vernacular_title: Le traitement des épistaxis de la maladie de Rendu-Osler par injection intramuqueuse d'éthibloc.